Nivolumab Plus Gemcitabine–Cisplatin for Advanced Urothelial Carcinoma
Read it now on PracticeUpdate.com
Read it now on PracticeUpdate.com
Program: Oral and Poster Abstracts Session: 301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational: Poster II Hematology Disease Topics & Pathways: Research, Bleeding and…
Abstract. Abstract 3989Poster Board III-925Introduction. Antiphospholipid antibodies (APAs) (lupus anticoagulant (LA), anti-beta2 glycoprotein I (anti-B2GPI) an
DOI: 10.20452/pamw.1415, Published online: August 22, 2012, Authors: Radosław Jeleniewicz, Maria Majdan, Bożena Targońska‑Stępniak, Magdalena Dryglewska
Objectives The long-term prognosis of individuals fulfilling the laboratory criteria, but not clinical criteria, of antiphospholipid syndrome (APS) has not been…
Stratifying and matching by the propensity score are increasingly popular approaches to deal with confounding in medical studies investigating effects of a treatment or exposure.…
Antiphospholipid syndrome (APS) is a thromboinflammatory disorder characterized by thrombosis and/or recurrent fetal loss accompanied by persistently positive t
PURPOSE Although chimeric antigen receptor T therapy (CAR-T) cells are an established therapy for relapsed/refractory multiple myeloma (RRMM), there are no established models predicting outcome…
Pre-register for the Your Healthy Java Health Fair on Saturday, May 11, 2024, from 11:00 AM to 3:00 PM at the Thelma Burns Building |…
Ghulam “Manni” Mohyuddin and Aaron “Papa Heme” Goodman takes on overtreatment in plasma cell neoplasms!
Antibody-drug conjugates (ADCs) embody a simple, but elegant, vision for cancer therapy—the delivery of a potent cytotoxic agent to tumor cells with minimal damage to…